Laboratory-based surveillance of Salmonella serotype typhi infections in the United States: Antimicrobial resistance on the rise

JAMA

Volumn 283, Issue 20, 2000, Pages 2668-2673

  Ackers, Marta Louise ^a,c   Puhr, Nancy D ^b   Tauxe, Robert V ^b   Mintz, Eric D ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM ISOLATION; CHILD; FEMALE; HEALTH CARE POLICY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; SALMONELLA TYPHI; SALMONELLOSIS; VACCINATION;

EID: 0034738125     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.20.2668     Document Type: Article

References (28)

1. Rice PA, Baine WB, Gangarosa EJ. Salmonella typhi infections in the United States, 1967-1972: increasing importance of international travelers. Am J Epidemiol. 1977;106:160-166.
2. Ryan CA, Hargrett-Bean NT, Blake PA. Salmonella typhi infections in the United States, 1975-1984: increasing role of foreign travel. Rev Infect Dis. 1989;11:1-8.
3. Mermin JH, Townes JM, Gerber M, Dolan N, Mintz ED, Tauxe RV. Typhoid fever in the United States, 1985-1994: changing risks of international travel and increasing antimicrobial resistance. Arch Intern Med. 1998;158:633-638.
4. Sudarsana J, NairL, Devi KI. Multidrug resistant Salmonella typhi in Calicut, south India. Indian J Med Res. 1992;95:68-70.
5. Rao PS, Rajashekar V, Varghese GK, Shivananda PG. Emergence of multidrug-resistant Salmonella typhi in rural southern India. Am J Trop Med Hyg. 1993; 48:108-111.
6. Atkins BL, Gottlieb T. Emerging drug resistance and vaccination for typhoid fever. JAMA. 1998;279:579.
7. Agarwal V, Brahmne RB, Dhanvijay AG, Jalgaonkar PD, Pathak AA, Saoji AM. Antibiogram, phage types and biotypes of Salmonella typhi isolated in Nagpur. Indian J Med Res. 1992;95:14-16.
8. Chandra R, Srinivasan S, Nalini P, Rao RS. Multidrug-resistant enteric fever. Am J Trop Med Hyg. 1992;95: 284-287.
9. Pillai PK, Prakash K. Current status of drug resistance and phage types of Salmonella typhi in India. Indian J Med Res. 1993;97:154-158.
10. Nguyen TA, Ha Ba K, Nguyen TD. Typhoid fever in South Vietnam, 1990-1993 [in French]. Bull Soc Pathol Exot. 1993;86:476-478.
11. Coovadia YM, Gathiran V, Bhamjee A. An outbreak of multiresistant Salmonella typhi in South Africa. QJM. 1992;82:91-100.
12. Zhang L. Mechanism of multiresistant Salmonella typhi. Chung Hua I Hsueh Tsa Chih. 1991;71: 314-317, 324.
13. Bhutta ZA, Naqvi SH, Razzaq RA, et al. Multidrug-resistant typhoid in children: presentation and clinical features. Rev Infect Dis. 1991;13:832-836.
14. Rowe B, Ward LR, Threlfall EJ. Treatment of multiresistant typhoid fever. Lancet. 1991;337:1422.
15. Gulati S, Narwaha RK, Prakash D, et al. Multidrug-resistant Salmonella typhi - a need for therapeutic reappraisal. Ann Trop Paediatr. 1992;12:137-141.
16. Umasankar S, Wall RA, Berger J. A case of ciprofloxacin-resistant typhoid fever. Bur. 1992;2:R139-R140.
17. Rowe B, Ward LR, Threlfall EJ. Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis. 1997;24(suppl 1):S106-S109.
18. Daga MK, Sarin K, Sarkar R. A study of culture-positive multidrug-resistant enteric fever - changing pattern and emerging resistance to ciprofloxacin. I Assoc Phys India. 1994;42:599-600.
19. Bhatia RS. Typhoid fever, not responding to ciprofloxacin therapy. J Assoc Phys India. 1992;40:705-706.
20. Threfall EJ, Ward LR, Skinner JA, Smith HR, Lacey S. Ciprofloxacin-resistant Salmonella typhi and treatment failure. Lancet. 1999;353:1590-1591.
21. Saha SK, Tulukder SY, Islam M, Saha S. A highly ceftriaxone-resistant Salmonella typhi in Bangladesh. Pediatr Infect Dis J. 1999;18:387.
22. National Committee for Clinical Laboratory Standards. Performance Standards of Antimicrobial Disk Susceptibility Tests. Wayne, Pa: National Committee for Clinical Laboratory Standards; 1995. Publication M100-S6.
23. Huang M-B, Baker CN, Banerjee S, Tenover FC. Accuracy of the E test for determining the antimicrobial susceptibility of stapnylococci, enterococci, Campylobacter jejuni and antimicrobial resistant enteric gram-negative bacteria. J Clin Microbiol. 1992;30: 3243-3248.
24. US Travel and Tourism Administration. Abstract of International Travel to and From the United States 1996. Washington, DC: US Travel and Tourism Administration; 1998:4-29.
25. Kleinbaum D, Kupper L, Morgenstern H. Epidemiologic Research. Belmont, Calif: Wadsworth; 1982:419
26. Wain J, Hoa NT, Chinh NT, et al. Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment. Clin Infect Dis. 1997;25:1404-1410.
27. Mahon BE, Mintz ED, Greene KD, Wells JG, Tauxe RV. Reported cholera in the United States, 1992-1994: a reflection of global changes in cholera epidemiology. JAMA. 1996;276:307-312.
28. Centers for Disease Control and Prevention. Health Information for International Travel 1996-1997. Atlanta, Ga: Centers for Disease Control and Prevention; 1997:199.